The power of AI (artificial intelligence) will be central to Avid’s product offerings at the NAB Show between April 13 and 17 in Las Vegas. For instance, Avid’s Inspiration Station open sessions at ...

BURLINGTON, Mass.—Avid has signed a strategic collaboration agreement with Amazon Web Services (AWS), to deliver a cloud-based production framework that helps film and television production companies ...

BURLINGTON, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Avid ® (NASDAQ: AVID), a leading technology provider that powers the media and entertainment industry, today announced that it has entered into a ...

Forbes contributors publish independent expert analyses and insights. Technology journalist specializing in audio, computing and Apple Macs. Is there any other piece of audio equipment that’s quite so ...

avid hotels has more than 200 hotels in its global pipeline. Launched in 2017, the midscale “avid” brand from InterContinental Hotels Group (IHG) is one of the company’s newest and continues to expand ...

The maker of the Media Composer editing system and Pro Tools audio post tool has once again become a private company. By Carolyn Giardina Tech Editor An affiliate of private equity firm STG has ...

Avid — the maker of the widely used Media Composer editing system and ProTools audio post production tool — named Wellford Dillard as its CEO, succeeding Jeff Rosica, who is staying with the company ...

Avid Bioservices (NASDAQ:CDMO) rose 1.6% as a holder said that it's opposed the planned $12.50 a share sale to GHO Capital Partners and Ampersand Capital Partners. Punch & Associates, which has a 4.5% ...

AVID has unveiled a new pair of high-end floorstanding speakers as part of its 30th anniversary celebrations. The Evo Two expand the British brand's Evo line, promising, slightly confusingly, to ...

TUSTIN, Calif., Sept. 15, 2025 /PRNewswire/ -- Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth ...

Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital Partners is pulling out its life sciences checkbook once again. This week, ...